640 related articles for article (PubMed ID: 9346188)
1. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
4. Potential role of apolipoprotein-E in fibrillogenesis.
Gallo G; Wisniewski T; Choi-Miura NH; Ghiso J; Frangione B
Am J Pathol; 1994 Sep; 145(3):526-30. PubMed ID: 8080036
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary amyloidosis and non-amyloid immunoglobulin deposits].
Cordier JF
Rev Mal Respir; 2008 Jun; 25(6):743-65. PubMed ID: 18772831
[TBL] [Abstract][Full Text] [Related]
6. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.
Khoor A; Myers JL; Tazelaar HD; Kurtin PJ
Am J Clin Pathol; 2004 Feb; 121(2):200-4. PubMed ID: 14983932
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distinction between amyloidosis and fibrillar glomerulopathy.
Casanova S; Donini U; Zucchelli P; Mazzucco G; Monga G; Linke RP
Am J Clin Pathol; 1992 Jun; 97(6):787-95. PubMed ID: 1595598
[TBL] [Abstract][Full Text] [Related]
10. Autopsy case with concurrent transthyretin and immunoglobulin amyloidosis.
Shintani-Domoto Y; Ishino K; Naiki H; Sakatani T; Ohashi R
Pathol Int; 2022 Jan; 72(1):65-71. PubMed ID: 34637570
[TBL] [Abstract][Full Text] [Related]
11. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
[TBL] [Abstract][Full Text] [Related]
12. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
13. [The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].
Adam Z; Elleder M; Moulis M; Tichý M; Cervinková I; Rehák Z; Koukalová R; Fojtík Z; Hanke I; Pour L; Krejčí M; Zahradová L; Szturz P; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Mar; 58(3):241-52. PubMed ID: 22486293
[TBL] [Abstract][Full Text] [Related]
14. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
[TBL] [Abstract][Full Text] [Related]
15. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
Kaplan B; Livneh A; Gallo G
Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
[TBL] [Abstract][Full Text] [Related]
16. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
Grogg KL; Aubry MC; Vrana JA; Theis JD; Dogan A
Am J Surg Pathol; 2013 Mar; 37(3):406-12. PubMed ID: 23282974
[TBL] [Abstract][Full Text] [Related]
17. Amyloid deposition in primary pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Satani T; Yokose T; Kaburagi T; Asato Y; Itabashi M; Amemiya R
Pathol Int; 2007 Nov; 57(11):746-50. PubMed ID: 17922687
[TBL] [Abstract][Full Text] [Related]
18. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
19. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
Gallo G; Picken M; Frangione B; Buxbaum J
Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
[TBL] [Abstract][Full Text] [Related]
20. Induction in mice of human light-chain-associated amyloidosis.
Solomon A; Weiss DT; Pepys MB
Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
